Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (NCT04924322)
Age-dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-associated Thrombosis in Critically Ill Children
🩺 Plain-English Summary (8th-Grade Level)
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Who can join: Review the eligibility criteria below.
Location: Children's of Alabama — Birmingham, Alabama
Age range: Not specified to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (22 Sites)
- Children's of Alabama — Birmingham, Alabama
- Arkansas Children's Hospital — Little Rock, Arkansas
- Children's Hospital Colorado — Aurora, Colorado
- Yale-New Haven Children's Hospital — New Haven, Connecticut
- University of Florida -UF Health — Gainesville, Florida
- Johns Hopkins All Children's — St. Petersburg, Florida
- Children's Hospital of Illinois at OSF Saint Francis Medical Center — Peoria, Illinois
- Stead Family Children's Hospital — Iowa City, Iowa
- Children's Hospital St. Louis — St Louis, Missouri
- Hassenfeld Children's Hospital — New York, New York
- New York Presbyterian Hospital — New York, New York
- Golisano Children's Hospital — Rochester, New York
- Maria Fareri Children's Hospital — Valhalla, New York
- UH Rainbow Babies & Children's Hospital — Cleveland, Ohio
- Nationwide Children's Hospital — Columbus, Ohio
- University of Oklahoma — Oklahoma City, Oklahoma
- Penn State Hershey Children's Hospital — Hershey, Pennsylvania
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
- Dell Children's Medical Canter — Austin, Texas
- UTSW Medical Center; Children's Medical Center of Dallas — Dallas, Texas
- Children's Hospital of Richmond — Richmond, Virginia
- Children's Hospital Wisconsin — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (203) 785-4651
Email: vince.faustino@yale.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Deep Venous Thrombosis
- FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease — Little Rock, Arkansas
- Second Line Endovascular Treatment in Acute DVT — Chicago, Illinois
Explore by condition: All Deep Venous Thrombosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.